Oppenheimer Asset Management says UnitedHealth is a Buy (NYSE:UNH)
Oppenheimer's Outlook on UnitedHealth: Oppenheimer Asset Management is optimistic about UnitedHealth (UNH) stock, predicting it could reach $650 following a breakout above $550, indicating a strong upward trend in the managed care sector.
Investment Opportunities: UNH currently trades at $582 and has shown significant gains over the past year; investors can also consider various ETFs that hold substantial allocations in UnitedHealth, with the iShares U.S. Healthcare Providers ETF having the largest at 24.16%.
Trade with 70% Backtested Accuracy
Analyst Views on DIA
About the author
US Stock Markets Poised for a Potential Relief Rally, According to Experts
Market Sell-Off: Commodity Trading Advisors (CTAs) have sold approximately $85 billion worth of U.S. equities over the last 30 trading sessions, marking the largest 30-day selling wave since the 2020 pandemic.
S&P 500 Correction: Analysts at Morgan Stanley suggest that the S&P 500 correction is nearing its final stage amid ongoing concerns related to the Iran war, with the index losing about 508 points or 7.39% over the past month.
Equity Sensitivity: The sensitivity of equities to rates is at its highest level in several years, with the 10-year Treasury yield closing at around 4.5%, which has pressured stock valuations.
Retail Sentiment: Retail sentiment regarding the S&P 500 ETF is currently in an "extremely bearish" territory, indicating a lack of confidence among investors in the market's near-term performance.
Powell States Fed Is Not Yet Confronting Policy Choices Due to Iran Oil Crisis – Emphasizes Central Bank's Awareness of the Larger Situation
Federal Reserve's Stance on Economic Impact: Jerome Powell stated that the Federal Reserve is not currently addressing the economic effects of the Iran war-induced oil supply shock, emphasizing the need to remain mindful of broader economic contexts when making monetary policy decisions.
Inflation Expectations: Powell noted that inflation expectations appear to be well-anchored beyond the short term, but acknowledged uncertainty regarding the economic impacts of the Iran war and rising energy prices.
Interest Rates and Demand: He clarified that the Fed's primary tool for controlling interest rates affects demand rather than supply, indicating that the rise in oil prices is a supply-side shock.
Monitoring Inflation: Powell stressed the importance of carefully monitoring inflation expectations, as a series of supply shocks could lead the public to anticipate higher inflation over time, impacting businesses and households.
Goldman Sachs Warns Market Is Overly Hawkish on Fed Rate Projections Amid Rising Oil Prices from Iran Conflict: Report
Goldman Sachs Analysis: Goldman Sachs reported that markets are currently too hawkish regarding the Federal Reserve's monetary policy outlook, influenced by ongoing geopolitical tensions and rising crude oil prices.
Interest Rate Projections: The probability of the Federal Reserve maintaining interest rates in the current range of 3.5% to 3.75% through 2026 is estimated to be between 79% and 97%, according to the CME FedWatch tool.
Market Sentiment: The market has priced in a larger hawkish shock than historical experiences would suggest, indicating heightened expectations for future interest rate adjustments.
Further Updates: For ongoing updates and corrections related to this developing story, readers are encouraged to follow Stocktwits.
El-Erian Cautions That Ongoing US Economic Shocks Could Result in Financial Instability Due to Iran Conflict: Report
Economic Warning: Mohamed El-Erian, Chief Economic Advisor at Allianz, cautioned that ongoing shocks to the U.S. economy from the escalating Iran war could lead to financial instability.
Inflation Impact: He highlighted that inflation shocks resulting from the conflict might reduce spending, particularly among low-income households.
Cascading Effects: El-Erian mentioned that various shocks, including energy and interest rate shocks, could compound the economic challenges if the situation continues.
Hope for Resolution: He expressed hope that the current trends would not persist, as they could lead to significant discussions about financial stability.
Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open
PMGC Holdings Update: PMGC Holdings announced an amended deal with MOA Life Plus to conduct human trials for EL-22 and EL-32, focusing on muscle and lean mass preservation.
Iterum Therapeutics Developments: Iterum Therapeutics filed a winding-up petition in Ireland, set for a hearing on April 13, 2026, while also announcing a significant increase in its stock value.
Lantheus Pharma Progress: Lantheus Pharma received FDA clearance for its new drug application for STAR-001, aimed at treating relapsed or refractory CNS malignancies, and saw a notable rise in its stock.
Market Sentiment: U.S. equities showed positive movement amid ongoing tensions in the Middle East, with retail sentiment regarding the S&P 500 ETF categorized as "extremely bearish."
SPY, QQQ, DIA Drop to Six-Month Lows as Wall Street Enters 'Correction Territory'
Market Decline: The Dow Jones Industrial Average dropped over 800 points, while the S&P 500 and Nasdaq Composite lost approximately 110 and 464 points, respectively, amid high volatility and concerns over the Middle East conflict.
Oil Prices Surge: Oil prices continued to rise, with U.S. West Texas Intermediate crude futures increasing by about 6% to around $100.40 per barrel, driven by supply disruptions from the ongoing war in the region.
Trump Administration's Stance: The Trump administration has indicated no immediate plans for a ground invasion of Iran, despite deploying thousands of troops to the Middle East, leaving markets uncertain about future military actions.
Tech Sector Impact: Major tech stocks, including Nvidia and Amazon, saw declines of over 2% and 4%, respectively, as investors pulled back from high valuations, contributing to the overall negative market sentiment.
US Stock Markets Poised for a Potential Relief Rally, According to Experts
Market Sell-Off: Commodity Trading Advisors (CTAs) have sold approximately $85 billion worth of U.S. equities over the last 30 trading sessions, marking the largest 30-day selling wave since the 2020 pandemic.
S&P 500 Correction: Analysts at Morgan Stanley suggest that the S&P 500 correction is nearing its final stage amid ongoing concerns related to the Iran war, with the index losing about 508 points or 7.39% over the past month.
Equity Sensitivity: The sensitivity of equities to rates is at its highest level in several years, with the 10-year Treasury yield closing at around 4.5%, which has pressured stock valuations.
Retail Sentiment: Retail sentiment regarding the S&P 500 ETF is currently in an "extremely bearish" territory, indicating a lack of confidence among investors in the market's near-term performance.
Powell States Fed Is Not Yet Confronting Policy Choices Due to Iran Oil Crisis – Emphasizes Central Bank's Awareness of the Larger Situation
Federal Reserve's Stance on Economic Impact: Jerome Powell stated that the Federal Reserve is not currently addressing the economic effects of the Iran war-induced oil supply shock, emphasizing the need to remain mindful of broader economic contexts when making monetary policy decisions.
Inflation Expectations: Powell noted that inflation expectations appear to be well-anchored beyond the short term, but acknowledged uncertainty regarding the economic impacts of the Iran war and rising energy prices.
Interest Rates and Demand: He clarified that the Fed's primary tool for controlling interest rates affects demand rather than supply, indicating that the rise in oil prices is a supply-side shock.
Monitoring Inflation: Powell stressed the importance of carefully monitoring inflation expectations, as a series of supply shocks could lead the public to anticipate higher inflation over time, impacting businesses and households.
Goldman Sachs Warns Market Is Overly Hawkish on Fed Rate Projections Amid Rising Oil Prices from Iran Conflict: Report
Goldman Sachs Analysis: Goldman Sachs reported that markets are currently too hawkish regarding the Federal Reserve's monetary policy outlook, influenced by ongoing geopolitical tensions and rising crude oil prices.
Interest Rate Projections: The probability of the Federal Reserve maintaining interest rates in the current range of 3.5% to 3.75% through 2026 is estimated to be between 79% and 97%, according to the CME FedWatch tool.
Market Sentiment: The market has priced in a larger hawkish shock than historical experiences would suggest, indicating heightened expectations for future interest rate adjustments.
Further Updates: For ongoing updates and corrections related to this developing story, readers are encouraged to follow Stocktwits.
El-Erian Cautions That Ongoing US Economic Shocks Could Result in Financial Instability Due to Iran Conflict: Report
Economic Warning: Mohamed El-Erian, Chief Economic Advisor at Allianz, cautioned that ongoing shocks to the U.S. economy from the escalating Iran war could lead to financial instability.
Inflation Impact: He highlighted that inflation shocks resulting from the conflict might reduce spending, particularly among low-income households.
Cascading Effects: El-Erian mentioned that various shocks, including energy and interest rate shocks, could compound the economic challenges if the situation continues.
Hope for Resolution: He expressed hope that the current trends would not persist, as they could lead to significant discussions about financial stability.
Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open
PMGC Holdings Update: PMGC Holdings announced an amended deal with MOA Life Plus to conduct human trials for EL-22 and EL-32, focusing on muscle and lean mass preservation.
Iterum Therapeutics Developments: Iterum Therapeutics filed a winding-up petition in Ireland, set for a hearing on April 13, 2026, while also announcing a significant increase in its stock value.
Lantheus Pharma Progress: Lantheus Pharma received FDA clearance for its new drug application for STAR-001, aimed at treating relapsed or refractory CNS malignancies, and saw a notable rise in its stock.
Market Sentiment: U.S. equities showed positive movement amid ongoing tensions in the Middle East, with retail sentiment regarding the S&P 500 ETF categorized as "extremely bearish."
SPY, QQQ, DIA Drop to Six-Month Lows as Wall Street Enters 'Correction Territory'
Market Decline: The Dow Jones Industrial Average dropped over 800 points, while the S&P 500 and Nasdaq Composite lost approximately 110 and 464 points, respectively, amid high volatility and concerns over the Middle East conflict.
Oil Prices Surge: Oil prices continued to rise, with U.S. West Texas Intermediate crude futures increasing by about 6% to around $100.40 per barrel, driven by supply disruptions from the ongoing war in the region.
Trump Administration's Stance: The Trump administration has indicated no immediate plans for a ground invasion of Iran, despite deploying thousands of troops to the Middle East, leaving markets uncertain about future military actions.
Tech Sector Impact: Major tech stocks, including Nvidia and Amazon, saw declines of over 2% and 4%, respectively, as investors pulled back from high valuations, contributing to the overall negative market sentiment.
